Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jul 31, 2025 · Filed Aug 4, 2025
A Larimar Therapeutics director paid $8.32M out of pocket for Larimar Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$8,319,782
Shares × reported transaction price
$1M+
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
2 days after results of Jul 29, 2025, 14 days before results of Aug 14, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.1% | +2.3% | −3.4% |
| 30 days | +3.5% | +3.4% | +0.1% |
| 90 days | +3.7% | +8.8% | −5.1% |
| 180 days | −6.2% | +10.7% | −16.9% |
| 365 days | +9.6% | +22.6% | −12.9% |
Past results only. Not a forecast.
Insider buying
Traded Jul 31, 2025 · filed 4 days later
A Larimar Therapeutics director paid $10.8M out of pocket for Larimar Therapeutics shares.
Insider buying
Traded Jul 31, 2025 · filed 4 days later
A Larimar Therapeutics director paid $10.8M out of pocket for Larimar Therapeutics shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.